Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19.
Nurpeisova A, Khairullin B, Abitaev R, Shorayeva K, Jekebekov K, Kalimolda E, Kerimbayev A, Akylbayeva K, Abay Z, Myrzakhmetova B, Nakhanov A, Absatova Z, Nurabayev S, Orynbayev M, Assanzhanova N, Abeuov K, Kutumbetov L, Kassenov M, Abduraimov Y, Zakarya K. Nurpeisova A, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2087412. doi: 10.1080/21645515.2022.2087412. Epub 2022 Aug 12. Hum Vaccin Immunother. 2022. PMID: 35960911 Free PMC article.
Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial.
Sarsenbayeva G, Volgin Y, Kassenov M, Issagulov T, Bogdanov N, Sansyzbay A, Abitay R, Nurpeisova A, Sagymbay A, Koshemetov Z, Stukova M, Buzitskaya Z, Кulmagambetov I, Karabayeva D, Davlyatshin T, Khairullin B. Sarsenbayeva G, et al. Among authors: nurpeisova a. J Med Virol. 2018 Jan;90(1):41-49. doi: 10.1002/jmv.24922. Epub 2017 Sep 25. J Med Virol. 2018. PMID: 28842994 Clinical Trial.
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters.
Zhugunissov K, Zakarya K, Khairullin B, Orynbayev M, Abduraimov Y, Kassenov M, Sultankulova K, Kerimbayev A, Nurabayev S, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Chervyakova O, Assanzhanova N, Burashev Y, Mambetaliyev M, Azanbekova M, Kopeyev S, Kozhabergenov N, Issabek A, Tuyskanova M, Kutumbetov L. Zhugunissov K, et al. Among authors: nurpeisova a. Front Microbiol. 2021 Sep 27;12:720437. doi: 10.3389/fmicb.2021.720437. eCollection 2021. Front Microbiol. 2021. PMID: 34646246 Free PMC article.
Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up.
Khairullin B, Zakarya K, Orynbayev M, Abduraimov Y, Kassenov M, Sarsenbayeva G, Sultankulova K, Chervyakova O, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Zhugunissov K, Assanzhanova N, Nurabayev S, Kerimbayev A, Yershebulov Z, Burashev Y, Kulmagambetov I, Davlyatshin T, Sergeeva M, Buzitskaya Z, Stukova M, Kutumbetov L. Khairullin B, et al. Among authors: nurpeisova a. EClinicalMedicine. 2022 Jun 25;50:101526. doi: 10.1016/j.eclinm.2022.101526. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35770251 Free PMC article.
[Selection of conditions for effective inactivation of Pseudopestis avium virus (Paramyxoviridae: Orthoavulovirus: Avian orthoavulovirus 1) for the production of a Newcastle disease vaccine].
Jekebekov KK, Assanzhanova NN, Nurpeisova AS, Ryskeldinova SZ, Absatova ZS, Abay ZS, Shayakhmetov YA, Omurtay AD, Moldagulova SU, Kalimolda EZ, Sadikalieva SO, Shorayeva KA, Zakarya KD. Jekebekov KK, et al. Among authors: nurpeisova as. Vopr Virusol. 2023 May 18;68(2):124-131. doi: 10.36233/0507-4088-163. Vopr Virusol. 2023. PMID: 37264847 Russian.
Safety and Protective Efficacy of a Candidate Vector-Based Vaccine for Bovine Tuberculosis.
Abay Z, Nurpeisova A, Shorayeva K, Sadikaliyeva S, Yespembetov B, Syrym N, Sarmykova M, Jekebekov K, Abitayev R, Tokkarina G, Kalimolda E, Absatova Z, Moldagulova S, Yoo HS, Kassenov M, Zakarya K, Abduraimov Y. Abay Z, et al. Among authors: nurpeisova a. Vaccines (Basel). 2023 Jul 4;11(7):1199. doi: 10.3390/vaccines11071199. Vaccines (Basel). 2023. PMID: 37515015 Free PMC article.
14 results